Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Orchard Therapeutics PLC (ORTX)
NASDAQ:ORTX
RESEARCH TOOLSreports
Orchard Therapeutics (ORTX) Stock Forecast & Price Target
1,688 Followers
See the Price Targets and Ratings of:
ORTX Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ORTX Stock 12 Month Forecast
There Are No Analyst Ratings for ORTX In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
ORTX Financial Forecast
Detailed List of Analyst Forecasts
Stifel Nicolaus
$16.00
Hold
-4.19%
Downside
Downgraded
10/05/23
Orchard Therapeutics downgraded to Hold from Buy at StifelOrchard Therapeutics downgraded to Hold from Buy at Stifel
Cantor Fitzgerald
$15.00
Buy
-10.18%
Downside
Initiated
06/26/23
Orchard Therapeutics (ORTX) Gets a Buy from Cantor Fitzgerald - TipRanks.comCantor Fitzgerald analyst Pete Stavropoulos reiterated a Buy rating on Orchard Therapeutics ( ORTX Research Report) today and set a price target of $15.00. The companys shares opened today at $5.30.
Oppenheimer
$34.00
Buy
103.59%
Upside
Reiterated
06/13/23
Orchard Therapeutics (ORTX) PT Lowered to $34 at OppenheimerOppenheimer analyst Hartaj Singh lowered the price target on Orchard Therapeutics (NASDAQ: ORTX) to $34.00 (from $37.00) while maintaining a Outperform rating.
Best Analysts Covering Orchard Therapeutics
Which Analyst Should I Follow If I Want to Buy ORTX and Sell After:
1 Month
3 Months
1 Year
Success Rate
2/3 ratings generated profit
Average Return
+152.87%
reiterated a buy rating 11 months ago
Copying Hartaj Singh's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +152.87% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ORTX Analyst Recommendation Trends
Rating
Jul 22
Mar 23
Jun 23
Oct 23
Jan 24
Strong Buy
2
4
6
5
2
Buy
1
1
0
0
0
Hold
0
0
0
1
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
5
6
6
4
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
ORTX Stock Forecast FAQ
What is ORTX’s average 12-month price target, according to analysts?
Currently, no data Available
What is ORTX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for ORTX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ORTX a Buy, Sell or Hold?
Currently, no data Available
What is Orchard Therapeutics PLC’s price target?
Currently, no data Available
What do analysts say about Orchard Therapeutics PLC?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of ORTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.